PD-(L)1 Inhibitors and Anlotinib Boost SCLC Therapy
In the relentless battle against extensive-stage small cell lung cancer (ES-SCLC), medical researchers are continuously seeking therapeutic strategies that offer ...
In the relentless battle against extensive-stage small cell lung cancer (ES-SCLC), medical researchers are continuously seeking therapeutic strategies that offer ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine